Nicotine Addiction
56
9
10
36
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
20 trials with published results (36%)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
5.4%
3 terminated out of 56 trials
92.3%
+5.8% vs benchmark
18%
10 trials in Phase 3/4
56%
20 of 36 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 36 completed trials
Clinical Trials (56)
Metabolome and Gut Microbiome Changes During Smoking Cessation in Long-term Drug Therapy in a Therapeutic Community
Factors Sustaining Tobacco Abstinence in Cancer Patients Treated With Radio-chemotherapy or Radiotherapy
Advancing VR-based Attentional Bias as a Biomarker for Tobacco Use Disorder
Effect of Product Characteristics on the Abuse Liability of Nicotine Pouches
Non-Invasive Deep Brain Neuromodulation for Smoking Cessation
Sex Differences in E-cig Perception: Study 1
Developing Evidence to Inform Regulatory Policy on Nicotine Content in E-Liquids
Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)
CONNECT Cancer Survivors With Tobacco Treatment
Acute Pharmacokinetic and Pharmacodynamic Effects of "Tobacco-Free" Oral Nicotine Pouches in Smokers
Semaglutide for Smoking Cessation in Patients With Diabetes
Effects of Semaglutide on Nicotine Intake
Assess the Influence of Nicotine Flux and Nicotine Form on Subjective Effects Related to Dependency
A Smartphone Application (ACT on Vaping) for Vaping Cessation in Young Adults
Quit Smoking Study for People Who Use E-Cigarettes
Neural Mechanisms Associated With Risk of Smoking Relapse
Nicotine's Effect on Cancer Stem Cell Markers in Human Umbilical Cord Tissue
Examining the Efficacy of a Newly Developed Smoking Cessation Program
Electronic Cigarettes as a Harm Reduction Strategy Among People Living With HIV/AIDS
Effectiveness of N-Acetylcysteine (NAC) in Motivational Enhancement Therapy for Nicotine Addiction